Showing 35,037 results

Pharmaceutical industry

Lenacapavir in South Africa: There are mounting concerns over transparency in cost

Editor's pick
Health-E News
15 September 2025
Finance & funding

This man needs HIV prevention drugs. The Kenyan clinics providing them will soon lose U.S. funding

Editor's pick
CBC
15 September 2025
Finance & funding

NIH is talking a lot about implementation science. I should be excited, but I’m nervous. Here's why.

Editor's pick
Elvin Geng (Substack)
12 September 2025
Conference announcements & declarations

Five Takeaways from the 2025 US Conference on HIV/AIDS

Editor's pick
My Fabulous Disease
11 September 2025
Coronavirus

Case Study Reveals How SARS-CoV-2 Evolves With Untreated HIV

Editor's pick
TheBodyPro
11 September 2025
Access to healthcare

Love, drugs and condoms: Couples with different HIV status in Kenya face a new reality

Editor's pick
NPR
11 September 2025
People & personal stories

Michael Seltzer, Who Raised Millions to Fight AIDS, Dies at 78

Editor's pick
The New York Times
10 September 2025
Exposure to HIV through medical procedures

Overall Incidence of HIV in Donated Blood Declined Despite Reduction in Deferral Periods

Editor's pick
American Journal of Managed Care
10 September 2025
Mpox (monkeypox)

WHO declares end of global emergency over mpox outbreak

Editor's pick
STAT (requires free registration)
8 September 2025
Pregnancy and vertical transmission

U=U applies for some pregnancies, but not breastfeeding

News
8 September 2025
PrEP policies & guidelines

U.S. will fulfill Biden-era pledge to provide lenacapavir PrEP to millions

Editor's pick
Science
8 September 2025
Bad science & bogus treatments

How ‘churnalism’ fuelled misinformation about HIV medication in South Africa’s water system

Editor's pick
Bhekisisa
8 September 2025
The search for a cure

The last gift: How bodies donated for research may help find a cure for HIV

Editor's pick
Science
5 September 2025
Injectable & long-acting PrEP

Why the medical community is thrilled by U.S. support for a 'breakthrough' HIV drug

Editor's pick
NPR
5 September 2025
Injectable & long-acting PrEP

US: CVS Will Not Cover Long-Acting HIV PrEP Lenacapavir For Now

Editor's pick
POZ
5 September 2025
Injectable & long-acting PrEP

Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries

Editor's pick
Gilead Sciences press release
5 September 2025
Cancer

Increased Risk of Chronic Health Conditions in Cancer Survivors With HIV

Editor's pick
TheBodyPro
4 September 2025
Access to healthcare

PrEP Insurance Denials Occur Frequently in U.S., Nationwide Survey Reveals

Editor's pick
TheBodyPro
4 September 2025
Experiences of stigma

How young Nigerians living with HIV are struggling with stigma

Editor's pick
Be In The Know
4 September 2025
Ageing & HIV

HIV is on the rise among older Africans, but care and research overlook this group – lessons from Kenya and South Africa

Editor's pick
The Conversation
4 September 2025
Injectable & long-acting PrEP

Twists and turns in the race to be South Africa’s first widely used HIV prevention injection

Editor's pick
Spotlight
4 September 2025
Injectable & long-acting PrEP

Kenya to roll out HIV jab lenacapavir in 2026, not a replacement for anti-retrovirals

Editor's pick
Africa Check
4 September 2025
Finance & funding

House GOP seeks to cut all U.S. HIV prevention programs in 2026

Editor's pick
Washington Blade
4 September 2025
Government, leadership & policy

Trump’s aid cuts in east Africa led to unwanted abortion and babies being born with HIV – report

Editor's pick
The Guardian
4 September 2025